Claudia Crescio

Azienda Ospedaliero Universitaria di Sassari

Papers

1

Total Citations

8

H-Index

1

About

Claudia Crescio is a surgical oncologist whose research focuses on the evolving role of transoral robotic surgery (TORS) in the management of oropharyngeal cancer, particularly in the context of HPV-driven disease. Her most cited work, a 2023 systematic review, critically examines whether current evidence supports the preferential recommendation of TORS over other modalities for p16-positive oropharyngeal squamous cell carcinomas. This contribution is pivotal in the ongoing debate over treatment de-intensification, as Crescio and her co-authors evaluate the balance between oncologic efficacy and functional preservation. By synthesizing data from international guidelines and emerging clinical studies, her review highlights the need for robust comparative trials before TORS can be universally recommended as a standard. With 8 citations in a short time, this paper has already influenced discussions among head and neck surgeons. Crescio’s work is essential reading for clinicians and researchers navigating the shift toward minimally invasive, personalized treatment strategies in HPV-positive oropharyngeal cancer, where reducing treatment morbidity without compromising survival is a central goal.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Do We Have Enough Evidence to Specifically Recommend Transoral Robotic Surgery in HPV−Driven Oropharyngeal Cancer? A Systematic Review
8 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: Azienda Ospedaliero Universitaria di Sassari

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago